Jimeno J - Search Results

1

Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.

Humeniuk R, Menon LG, Mishra PJ, Saydam G, Longo-Sorbello GS, Elisseyeff Y, Lewis LD, Aracil M, Jimeno J, Bertino JR, Banerjee D. Humeniuk R, et al. Among authors: jimeno j. Leukemia. 2007 Dec;21(12):2399-405. doi: 10.1038/sj.leu.2404911. Epub 2007 Aug 23. Leukemia. 2007. PMID: 17713546

2

Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.

Barboza NM, Medina DJ, Budak-Alpdogan T, Aracil M, Jimeno JM, Bertino JR, Banerjee D. Barboza NM, et al. Among authors: jimeno jm. Cancer Biol Ther. 2012 Jan 15;13(2):114-22. doi: 10.4161/cbt.13.2.18876. Cancer Biol Ther. 2012. PMID: 22336911 Free PMC article.

3

Heparin and suramin alter plitidepsin uptake via inhibition of GPCR coupled signaling.

Longo-Sorbello GS, Gao H, Mishra PJ, Kamen B, Soto A, Jimeno J, Aracil M, Paz de Paz MF, Bertino JR, Banerjee D. Longo-Sorbello GS, et al. Among authors: jimeno j. J Chemother. 2009 Nov;21(5):550-7. doi: 10.1179/joc.2009.21.5.550. J Chemother. 2009. PMID: 19933047

4

Levels of p27(kip1) determine Aplidin sensitivity.

Moneo V, Serelde BG, Leal JF, Blanco-Aparicio C, Diaz-Uriarte R, Aracil M, Tercero JC, Jimeno J, Carnero A. Moneo V, et al. Among authors: jimeno j. Mol Cancer Ther. 2007 Apr;6(4):1310-6. doi: 10.1158/1535-7163.MCT-06-0729. Mol Cancer Ther. 2007. PMID: 17431109

5

Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.

Li WW, Takahashi N, Jhanwar S, Cordon-Cardo C, Elisseyeff Y, Jimeno J, Faircloth G, Bertino JR. Li WW, et al. Among authors: jimeno j. Clin Cancer Res. 2001 Sep;7(9):2908-11. Clin Cancer Res. 2001. PMID: 11555609

6

Cell cycle arrest of human hematopoietic progenitors induced by medroxyprogesterone acetate.

Quesada AR, Jimeno JM, Márquez G, Aracil M. Quesada AR, et al. Among authors: jimeno jm. Exp Hematol. 1993 Oct;21(11):1413-8. Exp Hematol. 1993. PMID: 8405222

7

Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models.

Ling YH, Aracil M, Jimeno J, Perez-Soler R, Zou Y. Ling YH, et al. Among authors: jimeno j. Eur J Cancer. 2009 Jul;45(10):1855-64. doi: 10.1016/j.ejca.2009.03.003. Epub 2009 Apr 5. Eur J Cancer. 2009. PMID: 19346126 Free PMC article.

8

Adding pharmacogenomics to the development of new marine-derived anticancer agents.

Jimeno J, Aracil M, Tercero JC. Jimeno J, et al. J Transl Med. 2006 Jan 9;4:3. doi: 10.1186/1479-5876-4-3. J Transl Med. 2006. PMID: 16401350 Free PMC article.

9

Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound.

Serova M, de Gramont A, Bieche I, Riveiro ME, Galmarini CM, Aracil M, Jimeno J, Faivre S, Raymond E. Serova M, et al. Among authors: jimeno j. Mar Drugs. 2013 Mar 20;11(3):944-59. doi: 10.3390/md11030944. Mar Drugs. 2013. PMID: 23519149 Free PMC article.

10

In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development.

Bresters D, Broekhuizen AJ, Kaaijk P, Faircloth GT, Jimeno J, Kaspers GJ. Bresters D, et al. Among authors: jimeno j. Leukemia. 2003 Jul;17(7):1338-43. doi: 10.1038/sj.leu.2402972. Leukemia. 2003. PMID: 12835722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters